SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-303209
Filing Date
2014-08-08
Accepted
2014-08-08 16:31:06
Documents
15
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d728321d10q.htm 10-Q 682610
2 EX-3..1 d728321dex31.htm EX-3.1 7020
3 EX-10.6 d728321dex106.htm EX-10.6 153285
4 EX-10.7 d728321dex107.htm EX-10.7 9745
5 EX-10.8 d728321dex108.htm EX-10.8 615929
6 EX-31.1 d728321dex311.htm EX-31.1 9240
7 EX-31.2 d728321dex312.htm EX-31.2 9611
8 EX-32.1 d728321dex321.htm EX-32.1 3897
9 EX-32.2 d728321dex322.htm EX-32.2 4319
  Complete submission text file 0001193125-14-303209.txt   7172241

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT slxp-20140630.xml EX-101.INS 789508
11 XBRL TAXONOMY EXTENSION SCHEMA slxp-20140630.xsd EX-101.SCH 74321
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE slxp-20140630_cal.xml EX-101.CAL 67631
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxp-20140630_def.xml EX-101.DEF 292747
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxp-20140630_lab.xml EX-101.LAB 567558
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxp-20140630_pre.xml EX-101.PRE 400427
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 141027860
SIC: 2834 Pharmaceutical Preparations